“Rosemarie Day, founder and CEO of Day Health Strategies and former deputy director of Massachusetts’ health care insurance marketplace, agreed that the joint venture could potentially disrupt the role that so-called pharmacy benefit managers, or PBMs, play in negotiating prices between pharmaceutical companies and insurers.
“There’s going to be a lot of discussion and ways to think about how to bring more transparency to the situation,” Day said. “I would think Amazon and all three (companies) combined could bring some great technology tools to put more information in the hands of consumers.”
How the joint venture pays for care for its employees could help shape the market, Day added, specifically by developing health care budgets for employees or negotiated bundled payments for certain kinds of procedures.
“They could do interesting experiments and push the needle on that in the private market,” she said.”
Read the full article here.